DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $19,374,000 | +1.5% | 87,215 | -1.6% | 0.33% | -11.6% |
| Q3 2020 | $19,095,000 | +20.2% | 88,678 | -1.3% | 0.37% | +14.1% |
| Q2 2020 | $15,885,000 | +25.8% | 89,834 | -1.5% | 0.33% | +10.5% |
| Q1 2020 | $12,624,000 | -9.8% | 91,209 | 0.0% | 0.30% | +8.1% |
| Q4 2019 | $13,999,000 | +6.6% | 91,209 | +0.3% | 0.27% | -0.7% |
| Q3 2019 | $13,137,000 | +2.3% | 90,959 | +1.2% | 0.28% | +0.4% |
| Q2 2019 | $12,842,000 | +8.5% | 89,852 | +0.2% | 0.27% | +11.8% |
| Q1 2019 | $11,834,000 | +32.0% | 89,635 | +3.1% | 0.24% | +9.9% |
| Q4 2018 | $8,967,000 | -4.7% | 86,959 | +0.5% | 0.22% | +12.1% |
| Q3 2018 | $9,406,000 | +10.5% | 86,566 | +0.4% | 0.20% | +4.2% |
| Q2 2018 | $8,511,000 | +1.7% | 86,250 | +0.9% | 0.19% | -3.0% |
| Q1 2018 | $8,372,000 | +5.8% | 85,509 | +0.3% | 0.20% | +7.7% |
| Q4 2017 | $7,914,000 | +8.7% | 85,265 | +0.5% | 0.18% | +2.8% |
| Q3 2017 | $7,280,000 | +1.8% | 84,864 | +0.1% | 0.18% | -0.6% |
| Q2 2017 | $7,154,000 | -0.8% | 84,776 | +0.6% | 0.18% | -3.2% |
| Q1 2017 | $7,211,000 | +11.2% | 84,309 | +1.3% | 0.18% | +5.7% |
| Q4 2016 | $6,482,000 | +0.6% | 83,267 | +1.3% | 0.18% | -4.9% |
| Q3 2016 | $6,444,000 | -20.9% | 82,205 | +1.9% | 0.18% | -22.4% |
| Q2 2016 | $8,151,000 | +7.9% | 80,704 | +1.3% | 0.24% | +2.6% |
| Q1 2016 | $7,554,000 | +4.4% | 79,631 | +2.2% | 0.23% | +2.2% |
| Q4 2015 | $7,234,000 | +10.3% | 77,887 | +1.2% | 0.23% | +2.3% |
| Q3 2015 | $6,556,000 | -3.4% | 76,937 | -3.0% | 0.22% | +6.2% |
| Q2 2015 | $6,787,000 | +1.1% | 79,295 | +0.3% | 0.21% | +2.0% |
| Q1 2015 | $6,714,000 | -65.7% | 79,077 | -65.4% | 0.20% | +48.9% |
| Q4 2014 | $19,588,000 | +12.6% | 228,535 | -0.2% | 0.14% | +0.7% |
| Q3 2014 | $17,396,000 | -10.1% | 228,954 | -6.8% | 0.14% | -9.3% |
| Q2 2014 | $19,344,000 | +4.7% | 245,703 | -0.3% | 0.15% | 0.0% |
| Q1 2014 | $18,474,000 | -3.2% | 246,320 | -0.3% | 0.15% | -3.2% |
| Q4 2013 | $19,078,000 | -4.5% | 247,120 | -14.3% | 0.16% | -31.7% |
| Q3 2013 | $19,980,000 | -26.1% | 288,234 | -32.5% | 0.23% | -23.6% |
| Q2 2013 | $27,048,000 | – | 427,294 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |